The Combination of SGLT-2 inhibitors and GLP-1 Receptor Agonists

EMA press briefing on EU actions to tackle shortages of GLP-1 receptor agonists | European Medicines Agency (EMA)

Head to Head Study: Insulin vs. GLP-1 Receptor Agonists

GLP-1 Receptor Agonist and Stroke Prevention in Patients With and Without Diabetes

Optimizing the Use of Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes: Executive Summary

GLP-1 RA as a First Injectable for T2D: What Is the Safety and Efficacy of Two Different GLP-1 RA Options From This Trial?